Search results
Results From The WOW.Com Content Network
Two systematic reviews identified that indapamide with or without perindopril significantly reduced all cause mortality in young-elderly patients with a history of stroke, cardiovascular disease and type 2 diabetes mellitus, when greater reductions in mean office blood pressure are achieved, significant cardiovascular benefit was only observed ...
The Non-Insured Health Benefits (NIHB) program provides medically necessary coverage for eligible First Nations and Inuit in Canada. It is administered by Health Canada and covers benefit claims for certain drugs, dental care, vision care, medical supplies and equipment, short-term crisis intervention mental health counselling, and medical transportation. [1]
Programs vary by province. In Ontario, for example, most prescriptions for youths under the age of 24 are covered by the Ontario health insurance plan if no private insurance plan is available. [43] Competitive practices such as advertising are kept to a minimum, thus maximizing the percentage of revenues that go directly towards care.
Using a fixed combination of an ACE inhibitor and a chlorosulfamoyl diuretic leads to additive synergy of the antihypertensive effects of the two constituents. Its pharmacological properties are derived from those of each of the components taken separately, in addition to those due to the additive synergistic action of the two constituents, when combined, on vascular endothelium ...
The Health Professions Appeal and Review Board (HPARB) is an independent adjudicative agency which reviews decisions made by the 28 self-regulating health professions in Ontario. [1] The Board also holds hearings concerning physicians' hospital privileges under the Public Hospitals Act.
The moiety is also present in other medications that are not antimicrobials, including thiazide diuretics (including hydrochlorothiazide, metolazone, and indapamide, among others), loop diuretics (including furosemide, bumetanide, and torsemide), acetazolamide, sulfonylureas (including glipizide, glyburide, among others), and some COX-2 ...
The Ontario Health Premium (OHP) is a component of Ontario's Personal Income Tax system. The OHP is based on taxable income for a taxation year. As of May 2010, an Ontario resident with taxable income (i.e., income after subtracting allowable deductions) of $21,000 pays $60 per year. With a taxable income of $22,000, the premium doubles to $120.
Patented Medicine Prices Review Board office in Ottawa. Bill C-22, which was passed in 1987, established a compulsory licensing system under which drug patent holders were required to allow competing drug manufacturers to import their patented drug in exchange for a very modest 4% royalty, which resulted in an increase in the market share of generic drugs.